Literature DB >> 24132050

Peripheral atherosclerosis in patients with arterial erectile dysfunction.

C Goksu1, M Deveer2, A K Sivrioglu3, P Goksu1, B Cucen2, S Parlak4, M Cetinkaya5, L Altin4.   

Abstract

Erectile dysfunction (ED) develops owing to psychogenic, organic or/and both of these two factors. The aim of this study was to investigate the relationship between penile cavernosal arterial flow and peripheral atherosclerosis in men with ED. This study was conducted on 102 patients who had presented to Radiology Clinic with a prediagnosis of ED. Diabetes, hypertension (HT) and smoking were recorded. Blood were taken from all patients for analysis of fasting blood glucose, total cholesterol and high-density lipoprotein level. All the patients underwent high-resolution penile colour Doppler ultrasound (CDUS). The peak-systolic velocity and the end-diastolic velocity values in the bilateral cavernosal arteries were recorded. At the same session, all the patients underwent evaluation for bilateral common carotid artery and femoral artery intima media thickness and for the presence of atherosclerotic plaque. Patients were classified as ED of arterial origin and non-arterial origin according to penile CDUS findings. Of the total 102 patients, 43 (42.2%) had arterial ED and the remaining 59 (57.8%) were contained in non-arterial ED. There was a significant difference between groups for diabetes mellitus (DM), HT, atherosclerotic cardiovascular diseases (ACVD) and total cholesterol level (P<0.05). There was also a significant difference between groups for the presence of plaque in the carotid and the femoral artery (P<0.05). The relationship between smoking and arterial ED was not found to be statistically significant (P>0.05). Non-diagnosed or silent DM, HT and ACVD can have roles in the etiology of arterial ED. Patients who are diagnosed as having arterial ED with Doppler Ultrasound should also be evaluated with B-mode ultrasonography for other peripheral vascular atherosclerotic processes. In this way, subclinical cases can be detected and further possible complications can be avoided.

Entities:  

Mesh:

Year:  2013        PMID: 24132050     DOI: 10.1038/ijir.2013.35

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  31 in total

Review 1.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

Review 2.  Vascular risk factors and erectile dysfunction.

Authors:  M E Sullivan; S R Keoghane; M A Miller
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

3.  Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors.

Authors:  Giorgia De Berardis; Fabio Pellegrini; Monica Franciosi; Maurizio Belfiglio; Barbara Di Nardo; Sheldon Greenfield; Sherrie H Kaplan; Maria C E Rossi; Michele Sacco; Gianni Tognoni; Miriam Valentini; Antonio Nicolucci
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

Review 4.  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors: 
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

5.  Frequency and determinants of erectile dysfunction in Italy.

Authors:  F Parazzini; F Menchini Fabris; A Bortolotti; A Calabrò; L Chatenoud; E Colli; M Landoni; M Lavezzari; P Turchi; A Sessa; V Mirone
Journal:  Eur Urol       Date:  2000-01       Impact factor: 20.096

6.  Comparison of selective internal iliac pharmaco-angiography, penile brachial index and duplex sonography with pulsed Doppler analysis for the evaluation of vasculogenic (arteriogenic) impotence.

Authors:  S C Mueller; H von Wallenberg-Pachaly; G E Voges; H H Schild
Journal:  J Urol       Date:  1990-05       Impact factor: 7.450

7.  The relationship between lipid profile and erectile dysfunction.

Authors:  M Nikoobakht; H Nasseh; M Pourkasmaee
Journal:  Int J Impot Res       Date:  2005 Nov-Dec       Impact factor: 2.896

8.  Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients.

Authors:  Ahmed I El-Sakka; Khalid A Tayeb
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

9.  Association of type and duration of diabetes with erectile dysfunction in a large cohort of men.

Authors:  Constance G Bacon; Frank B Hu; Edward Giovannucci; Dale B Glasser; Murray A Mittleman; Eric B Rimm
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

10.  The effect of diabetes mellitus treatment and good glycemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: a pilot study.

Authors:  Onder Yaman; Murat Akand; Alptekin Gursoy; Murat Faik Erdogan; Kadri Anafarta
Journal:  J Sex Med       Date:  2006-03       Impact factor: 3.802

View more
  4 in total

1.  FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.

Authors:  M El Assar; J M Sánchez-Puelles; I Royo; E López-Hernández; A Sánchez-Ferrer; J L Aceña; L Rodríguez-Mañas; J Angulo
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  The Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery.

Authors:  Özcan Gür; Selami Gurkan; Gunduz Yumun; Polat Turker
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-03-10       Impact factor: 1.520

Review 3.  The Association of Erectile Dysfunction and Cardiovascular Disease: A Systematic Critical Review.

Authors:  Omer A Raheem; Jeannie J Su; Joel R Wilson; Tung-Chin Hsieh
Journal:  Am J Mens Health       Date:  2016-02-04

4.  Analysis of cardiovascular risks for erectile dysfunction in Chinese patients with type 2 diabetes mellitus lacking clinical symptoms of cardiovascular diseases.

Authors:  Penghui Yuan; Delin Ma; Yucong Zhang; Xintao Gao; Jiaxin Wang; Rui Li; Zhuo Liu; Tao Wang; Yan Yang; Gang Yuan; Xuefeng Yu; Shaogang Wang; Jihong Liu; Xiaming Liu
Journal:  Transl Androl Urol       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.